Issue 34, 2024
From the journal:

RSC Advances

Correction: Study on mechanism of elemene reversing tumor multidrug resistance based on luminescence pharmacokinetics in tumor cells in vitro and in vivo

Liying Chen,a   Zhi Chen,*ab   Shuang Zheng,a   Luhui Fan,a   Lixin Zhu,ac   Jiandong Yu,a   Chaoyuan Tang,a   Qi Liud  and  Yang Xiong*a  

* Corresponding authors

a Department of Pharmaceutical Science, College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 311400, Zhejiang, China

b The First People’s Hospital of Jiande, Jiande 311600, Zhejiang, China

c Zhejiang Institute for Food and Drug Control, Hangzhou 310004, Zhejiang, China

d Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA

Abstract

Correction for ‘Study on mechanism of elemene reversing tumor multidrug resistance based on luminescence pharmacokinetics in tumor cells in vitro and in vivo’ by Liying Chen et al., RSC Adv., 2020, 10, 34928–34937, https://doi.org/10.1039/d0ra00184h.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D4RA90085E
Article type
Correction
Submitted
01 Aug 2024
Accepted
01 Aug 2024
First published
12 Aug 2024
This article is Open Access
Creative Commons BY license

RSC Adv., 2024,14, 25077-25078

Permissions

Request permissions

Correction: Study on mechanism of elemene reversing tumor multidrug resistance based on luminescence pharmacokinetics in tumor cells in vitro and in vivo

L. Chen, Z. Chen, S. Zheng, L. Fan, L. Zhu, J. Yu, C. Tang, Q. Liu and Y. Xiong, RSC Adv., 2024, 14, 25077 DOI: 10.1039/D4RA90085E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements